Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 7 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Korro Bio, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 40 | 49 | +9 |
| Shares | 6.56M | 6.91M | +345.4K (+5.3%) |
| Value | $301.5M | $618.6M | +$317.1M (+105.2%) |
New holders (11)
Institutions that held Korro Bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invesco Ltd. | 72,419 | $6.52M | 0.00% |
| Millennium Management LLC | 60,894 | $5.48M | 0.00% |
| Goldman Sachs Group Inc | 45,171 | $4.07M | 0.00% |
| Marshall Wace, LLP | 13,407 | $1.21M | 0.00% |
| Susquehanna International Group, LLP | 11,276 | $1.01M | 0.00% |
| Balyasny Asset Management LLC | 3,773 | $339.6K | 0.00% |
| Brevan Howard Capital Management LP | 3,602 | $324.2K | 0.03% |
| Charles Schwab Investment Management Inc | 3,147 | $283.2K | 0.00% |
| Quarry LP | 400 | $36.0K | 0.01% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 20 | $1.80K | 0.00% |
| Macquarie Group Ltd | 389 | $35 | 0.00% |
Sold out (2)
Institutions that held Korro Bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Orion Capital Management LLC | 20 | $959 |
| Group One Trading, L.P. | 4 | $192 |